Background: Acupotomy is a type of acupuncture where a scalpel-shaped needle (miniscalpel needle) is used instead of a normal acupuncture needle to exfoliate adhesion sites or to relax entrapped regions. This study aimed to identify the descriptive characteristics of patients who received acupotomy treatment at a single Korean Medicine Clinic.Methods: This retrospective review analyzed the medical charts of patients who had received acupotomy at least once from August 2017 to December 2019 at a single Korean Medicine Clinic. The demographic characteristics, chief complaints, acupotomy treatment sites, and principal diagnosis codes were analyzed.Results: We identified 551 outpatients; the average age was 52 ± 14.26 years and 49.9% were male. The patients underwent an average of 8.47 sessions of acupotomy. Altogether, 35.91% of the acupotomy treatments were administered to the spinal regions, of which 60.01% were in the lumbar region. The codes related to the lumbar spinal condition/disease which were used most frequently. The chief complaints were dizziness, lumbar spinal stenosis, and Dupuytren’s contracture in patients over 60 years of age.Conclusion: This is the 1st analysis of acupotomy treatment patterns in Korea to date. Acupotomy is primarily administered in the treatment of spinal conditions/diseases, especially for those involving the lumbar region. Future studies are necessary to determine the clinical outcomes of patients who receive acupotomy treatment and the safety of this treatment.
Background/Objectives: Liuwei Dihuang (LWDH) is a classical plant-derived herbal formula widely used for cognitive decline. This study aimed to evaluate its efficacy and safety in cognitive disorders and to explore its potential pharmacological mechanisms using network pharmacology. Methods: We searched 11 databases through November 2024 for randomized controlled trials comparing LWDH plus conventional therapy with conventional therapy alone in cognitive disorders. Meta-analysis was performed for clinical outcomes, and herb–compound–target and disease-target datasets were integrated to identify core molecular modules. Results: Twelve randomized controlled trials involving 1137 participants were included. Adjunctive LWDH was associated with improvements in Mini-Mental State Examination scores (MD = 2.34, 95% CI 0.88–3.79), activities of daily living, and quality of life. However, substantial heterogeneity and methodological limitations, including unclear randomization and blinding, were observed across studies, indicating a potential risk of bias. Fewer adverse events were reported in the LWDH plus conventional treatment group, although reporting quality was limited. The overall risk of bias was judged as “some concerns”. Network pharmacology analysis identified a broad set of overlapping genes between LWDH-associated targets and cognitive disorder-related genes, which were further refined through filtering procedures. Subsequent analyses suggested associations with pathways related to neurodegeneration, apoptosis, and central nervous system function; however, these findings are exploratory and based on in silico predictions. Conclusions: LWDH may be associated with potential adjunctive benefits in cognitive disorders. However, given the methodological limitations and clinical heterogeneity of the included studies, the findings should be interpreted with caution. The proposed pharmacological mechanisms are exploratory and require further validation. Well-designed randomized controlled trials are needed to establish more robust evidence.
28 February 2026 in Perspectives on Integrative Medicine
Background: Despite guideline-based evaluation of identifiable causes, many patients still have refractory or unexplained chronic cough, highlighting the need for adjunctive therapies. Real-world clinical evidence for Maimendong-Tang (MMDT) in primary Korean medicine is scarce.Methods: Medical records from 1 primary Korean medicine clinic were retrospectively reviewed. Adults with subacute or chronic cough who received MMDT for ≥ 2 weeks were included in the study. Outcomes were improvement in severity for cough and sputum. The data were summarized descriptively, cumulative proportions achieving ≥ 50% and ≥ 3-point cough-NRS reductions were calculated by visit and cough type, and exploratory k-means clustering (Jaccard distance) was performed, and herb-symptom bipartite networks were assessed.Results: Thirty-one patients were included (mean age 53.6 ± 14.8; 90% female; 14 subacute, 17 chronic). Inter-visit medians (IQR) were 35.5 (32.0-49.5), 34.5 (33.2-43.5), and 34.0 (34.0-42.0) days for Visits 1-2, 2-3, and 3-4. Cough NRS scores decreased from 7.95 ± 1.04 at Visit 1 to 3.14 ± 1.87 at Visit 2 (subacute 8.21 ± 0.97 → 2.58 ± 1.46; chronic 7.74 ± 1.06 → 3.63 ± 2.09), and sputum NRS scores from 3.18 ± 2.51 to 1.68 ± 1.72. By Visit 2, 67.7% achieved ≥ 50% cough reduction (subacute 85.7%; chronic 52.9%). No adverse events were observed. Clustering and herb-symptom networks showed no meaningful prescription-pattern differences by co-occurring symptoms; subacute- and chronicstratified networks resembled the overall network.Conclusion: MMDT prescription may be associated with a decrease in cough and sputum severity. Due to risk of bias, generalizability is limited; however, demographics, clinical characteristics, and treatment patterns, may provide foundational data for large-scale prospective studies.